Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Stake Decreased by Gilman Hill Asset Management LLC

Gilman Hill Asset Management LLC reduced its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 0.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 602,798 shares of the real estate investment trust’s stock after selling 759 shares during the period. Sabra Health Care REIT accounts for about 1.8% of Gilman Hill Asset Management LLC’s investment portfolio, making the stock its 7th largest position. Gilman Hill Asset Management LLC owned 0.25% of Sabra Health Care REIT worth $10,531,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently bought and sold shares of SBRA. VSM Wealth Advisory LLC acquired a new stake in Sabra Health Care REIT in the fourth quarter valued at approximately $26,000. Assetmark Inc. grew its position in shares of Sabra Health Care REIT by 33.4% during the fourth quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust’s stock worth $45,000 after buying an additional 656 shares in the last quarter. GF Fund Management CO. LTD. acquired a new stake in shares of Sabra Health Care REIT during the fourth quarter worth approximately $74,000. Jones Financial Companies Lllp grew its position in shares of Sabra Health Care REIT by 208.3% during the fourth quarter. Jones Financial Companies Lllp now owns 6,222 shares of the real estate investment trust’s stock worth $108,000 after buying an additional 4,204 shares in the last quarter. Finally, FIL Ltd grew its position in shares of Sabra Health Care REIT by 40.4% during the fourth quarter. FIL Ltd now owns 6,512 shares of the real estate investment trust’s stock worth $113,000 after buying an additional 1,873 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Health Care REIT Stock Performance

Sabra Health Care REIT stock opened at $17.63 on Thursday. The company has a market cap of $4.19 billion, a PE ratio of 33.26, a P/E/G ratio of 1.97 and a beta of 0.88. The company has a fifty day moving average price of $17.54 and a two-hundred day moving average price of $17.31. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. Sabra Health Care REIT, Inc. has a 12 month low of $13.87 and a 12 month high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA) last released its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.01. The firm had revenue of $183.54 million during the quarter, compared to the consensus estimate of $180.23 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The firm’s revenue was up 10.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.35 earnings per share. Research analysts expect that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Health Care REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Friday, May 16th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.81%. The ex-dividend date was Friday, May 16th. Sabra Health Care REIT’s dividend payout ratio is presently 203.39%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Scotiabank raised their price target on shares of Sabra Health Care REIT from $18.00 to $19.00 and gave the stock a “sector perform” rating in a research report on Monday, May 12th. Truist Financial raised their price target on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Tuesday, March 18th. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $19.50.

Insider Buying and Selling at Sabra Health Care REIT

In other Sabra Health Care REIT news, Director Michael J. Foster sold 11,000 shares of the firm’s stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total value of $200,420.00. Following the sale, the director now directly owns 64,725 shares in the company, valued at approximately $1,179,289.50. This trade represents a 14.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.20% of the stock is currently owned by company insiders.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.